唾液腺感染疾病市場規模、佔有率和成長分析（按感染疾病類型、受累腺體、診斷方法、治療方法方法、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，全球唾液腺感染疾病市場規模將達到 64.4 億美元，到 2025 年將成長至 70.2 億美元，到 2033 年將成長至 141 億美元，預測期（2026-2033 年）的複合年成長率為 9.1%。

受多種因素影響，全球唾液腺感染疾病市場正經歷顯著成長。口腔感染疾病率的上升，尤其是在老年人，推動了對有效治療方法的需求不斷成長。唾液腺內視鏡和先進影像技術等診斷工具的創新，提高了早期發現感染的能力，從而改善了患者的治療效果。大眾對口腔健康問題的日益關注，促使患者傾向於選擇微創治療方法。此外，已開發國家醫療基礎設施的改善以及新興市場醫療服務可近性的提高，使得及時干預成為可能。這些趨勢不僅推動了市場擴張，也促進了唾液腺感染疾病治療方法和預防策略的進步，重塑了市場競爭格局。

全球唾液腺感染疾病市場促進因素

口腔感染疾病（包括細菌性涎腺炎和病毒性腮腺炎）的日益增多，顯著推動了全球唾液腺感染疾病治療市場的需求成長。口腔衛生不良、人口老化以及糖尿病等潛在疾病等因素進一步加劇了這個問題。隨著大眾對這些感染疾病的認知不斷提高，尋求及時醫療干預的患者數量也顯著增加。這一趨勢迫使醫療系統更加重視唾液腺疾病的早期診斷和專業治療方案，最終重塑了市場格局。

全球唾液腺感染疾病市場限制因素

全球唾液腺感染疾病市場面臨嚴峻挑戰，主要原因是農村和醫療資源匱乏地區對疾病的認知度較低。這種認知不足阻礙了早期診斷和適當治療，導致患者對症狀的解讀和尋求專科治療的方式不一致。這造成了病例漏報和感染疾病治療延誤，阻礙了醫療服務的公平取得。這個問題嚴重限制了市場的整體成長潛力，凸顯了加強教育和宣傳活動以提高患者認知和加速治療的必要性。

全球唾液腺感染疾病市場趨勢

唾液腺鏡檢查等微創診斷技術的應用已成為全球唾液腺感染疾病市場的一大趨勢。這些先進的診療手段在提高診斷準確性的同時，最大限度地減少了患者的不適感，並縮短了恢復時間。隨著醫療機構擴大將這些技術應用於臨床實踐，對高效且便利的診斷方案的需求預計將推動市場顯著成長和創新。這項轉變不僅反映了醫療產業對微創診療的普遍偏好，也標誌著唾液腺感染疾病治療領域變革時期時期，有助於改善病患的治療效果和滿意度。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境

全球唾液腺感染疾病市場規模（按感染疾病類型和複合年成長率分類）（2026-2033 年）

• 細菌感染疾病
• 病毒感染疾病
• 黴菌感染疾病
• 寄生蟲感染疾病

全球唾液腺感染疾病市場規模（依受累腺體分類）及複合年成長率（2026-2033 年）

• 腮腺感染疾病
• 下頷腺感染疾病
• 舌下腺感染疾病
• 小唾液腺感染疾病

全球唾液腺感染疾病市場規模（按診斷方法和複合年成長率分類）（2026-2033 年）

• 身體檢查
• 診斷影像技術
• 檢查室檢測
• 切片檢查/造影

全球唾液腺感染疾病市場規模（按治療方法和複合年成長率分類）（2026-2033 年）

• 藥物治療
• 外科手術
• 抽吸/引流
• 居家照護/輔助護理

全球唾液腺感染疾病市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院和診所
• 門診手術中心
• 口腔顎顏面外科診所
• 居家醫療/遠端醫療

全球唾液腺感染疾病市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• AbbVie Inc.
• Allergan
• AstraZeneca
• FUJIFILM Holdings Corporation
• GlaxoSmithKline plc.
• Johnson & Johnson Services Inc.
• Merck & Co., Inc.
• Pfizer Inc.
• Siemens Healthcare GmbH
• General Electric Company（GE Healthcare）
• Roche Holding AG
• Takeda Pharmaceutical Company
• Stryker Corporation
• Zimmer Biomet Holdings
• Philips Healthcare
• Canon Medical Systems Corporation
• Hologic Inc.
• Olympus Corporation
• BD
• Varian Medical Systems

結論與建議

Global Salivary Gland Infection Market size was valued at USD 6.44 Billion in 2024 and is poised to grow from USD 7.02 Billion in 2025 to USD 14.1 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The global salivary gland infection market is experiencing significant growth due to several influential factors. The rising incidence of oral infections, particularly among older populations, underscores the increasing demand for effective treatment options. Innovations in diagnostic tools such as sialendoscopy and advanced imaging techniques are enhancing early detection capabilities and improving patient outcomes. Growing public awareness about oral health issues is shifting patient preferences toward less invasive treatment modalities. Moreover, improved healthcare infrastructure in developed nations, coupled with enhanced access to medical services in emerging markets, is facilitating timely intervention. Collectively, these dynamics are not only propelling market expansion but also driving advancements in treatment and preventive strategies within the salivary gland infection sector, reshaping its competitive landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Salivary Gland Infection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Salivary Gland Infection Market Segments Analysis

Global Salivary Gland Infection Market is segmented by Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User and region. Based on Type of Infection, the market is segmented into Bacterial Infections, Viral Infections, Fungal Infections and Parasitic Infections. Based on Gland Affected, the market is segmented into Parotid Gland Infections, Submandibular Gland Infections, Sublingual Gland Infections and Minor Salivary Gland Infections. Based on Diagnosis Method, the market is segmented into Physical Examination, Imaging Techniques, Laboratory Testing and Biopsy / Sialography. Based on Treatment Type, the market is segmented into Medication, Surgical Procedures, Aspiration / Drainage and Home Care / Supportive Therapy. Based on End-User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Oral & Maxillofacial Clinics and Home Care / Telemedicine. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Salivary Gland Infection Market

The growing prevalence of oral infections, including bacterial sialadenitis and viral parotitis, significantly fuels the demand for treatment in the global salivary gland infection market. Contributing factors such as poor oral hygiene, advancing age, and underlying systemic health conditions like diabetes exacerbate this issue. As public awareness around these infections increases, there is a notable rise in patients seeking timely medical intervention. This trend compels healthcare systems to enhance their focus on early diagnosis and specialized treatment options for salivary gland disorders, ultimately shaping the landscape of care in the market.

Restraints in the Global Salivary Gland Infection Market

The Global Salivary Gland Infection market faces significant challenges due to the low awareness of these conditions in rural and underserved areas. This lack of awareness hinders early diagnosis and timely treatment, contributing to discrepancies in how patients interpret symptoms and seek specialist care. As a result, there is often underreporting of incidents and delays in addressing the infections, which poses a barrier to equitable healthcare access. This issue presents a considerable obstacle to the overall growth potential within the market, highlighting the need for improved education and outreach to enhance patient understanding and prompt treatment.

Market Trends of the Global Salivary Gland Infection Market

The Global Salivary Gland Infection market is witnessing a significant trend towards the adoption of minimally invasive diagnostic techniques, such as sialendoscopy. These advanced methods enhance diagnostic accuracy while minimizing patient discomfort and facilitating quicker recovery times. As healthcare providers increasingly integrate these technologies into their clinical practices, the demand for efficient and patient-friendly diagnostic options is expected to drive substantial growth and innovation within the market. This shift not only reflects a broader preference for less invasive procedures in healthcare but also indicates a transformative phase for the management of salivary gland infections, fostering improved patient outcomes and satisfaction.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Salivary Gland Infection Market Size by Type of Infection & CAGR (2026-2033)

• Market Overview
• Bacterial Infections
• Viral Infections
• Fungal Infections
• Parasitic Infections

Global Salivary Gland Infection Market Size by Gland Affected & CAGR (2026-2033)

• Market Overview
• Parotid Gland Infections
• Submandibular Gland Infections
• Sublingual Gland Infections
• Minor Salivary Gland Infections

Global Salivary Gland Infection Market Size by Diagnosis Method & CAGR (2026-2033)

• Market Overview
• Physical Examination
• Imaging Techniques
• Laboratory Testing
• Biopsy / Sialography

Global Salivary Gland Infection Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Medication
• Surgical Procedures
• Aspiration / Drainage
• Home Care / Supportive Therapy

Global Salivary Gland Infection Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Oral & Maxillofacial Clinics
• Home Care / Telemedicine

Global Salivary Gland Infection Market Size & CAGR (2026-2033)

• North America (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • US
  • Canada
• Europe (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Infection, Gland Affected, Diagnosis Method, Treatment Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (GE Healthcare)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations